| Project/Area Number |
62870030
|
|---|
| Research Category |
Grant-in-Aid for Developmental Scientific Research
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
内科学一般
|
|---|
| Research Institution | Osaka University Medical School |
|---|
Principal Investigator |
TANIGUCHI Naoyuki Professor Osaka University Medical School, 医学部, 教授 (90002188)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
KAMADA Takenobu Professor Osaka University Medical School, 医学部, 教授 (80028399)
|
|---|
| Project Period (FY) |
1987 – 1988
|
| Project Status |
Completed (Fiscal Year 1988)
|
| Budget Amount *help |
¥9,000,000 (Direct Cost: ¥9,000,000)
Fiscal Year 1988: ¥2,000,000 (Direct Cost: ¥2,000,000)
Fiscal Year 1987: ¥7,000,000 (Direct Cost: ¥7,000,000)
|
|---|
| Keywords | -glutamyltransferase / 糖鎖 / モノクローン抗体 / 肝癌 / γーグルタミルトランスペプチダーゼ |
|---|
| Research Abstract |
A monoclonal antibody, gammas-54-29 was raised against sugar chains of highly purified gamma-glutamyltransferase (gammaGT) from human primary hepatoma. The antibody preferentially bound to the small subunit of gammaGT from human hepatoma and kidney as evidenced by immunoblot analysis. Weak binding to the normal liver enzyme could be detected by solid-phase enzyme-linked immunosorbent assay (ELISA). With the use of this antibody, an ELISA was developed for the quantitation of immunoreactive gammaGT in human serum. Sera of 188 normal control subjects displayed a low level (9.4 mug/ml) of immunoreactive gammaGT. Highly elevated levels of immunoreactive gammaGT were detected in the sera of patients with primary hepatoma, metastatic liver cancer and hepatitis. The levels of gammaGT were within a normal range in the sera of patients with gastrointestinal cancers and patients with nonmalignant diseases such as liver cirrhosis and gallstones. The antibody has been shown to be useful for the diagnosis of some of the neoplastic diseases.
|
